Skip to content
Trial Eligibility
Menu

Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis

NCT04755699

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is an early feasibility trial to determine whether transcutaneous neuromuscular electrical stimulation, with or without transcutaneous spinal cord stimulation, using an investigational neurostimulation device improves functional arm/hand movements in individuals with paralysis or paresis due to a spinal cord injury or stroke and improves functional arm/hand or leg/foot movements in individuals with paralysis or paresis due to other brain or nerve injuries.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Healthy Volunteers
  • Spinal Cord Injury
  • Stroke
  • Paralysis
  • Paresis
  • Neurological Injury

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
18 to 75 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Northwell Health
Last updated on ClinicalTrials.gov
March 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Northwell Health's The Feinstein Institute for Medical Research · Manhasset, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.